Welcome to IsraPharm - Contact us at +972 7337 468 45 (Office)

Contact Us

Office Address

Weizman 14 st., Tel Aviv, Israel

Phone Number

+972 7337 46845 (Office)

Email Address

[email protected]



Add to Wishlist
Add to Wishlist


Indications for use Neupogen:
Neutropenia, febrile neutropenia in patients receiving intensive myelosuppressive cytotoxic chemotherapy for malignant diseases (with the exception of chronic myeloid leukemia and myelodysplastic syndrome), as well as neutropenia and its clinical consequences in patients receiving myeloablative therapy followed by allogeneic or autologous bone marrow transplantation;
Mobilization of peripheral blood stem cells, including after myelosuppressive therapy;
Severe congenital, intermittent or idiopathic neutropenia (absolute neutrophil count less than or equal to 0.5 x 109/l) in children and adults with a history of severe or recurrent infections;
persistent neutropenia (absolute neutrophil count less than or equal to 1.0 x 109/l) in patients with advanced HIV infection to reduce the risk of bacterial infections when other treatments cannot be used.

Active ingredient: Filgrastim

Storage temperature 4-8 degrees

Prescription medicine.

Additional information


30 MU/0.5 Ml, 48 MU/0.5 Ml